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A B S T R A C T
The present study examines long-term effects of occupational exposure to formaldehyde fumes on lung function. Forc-
ed spirometry and diffusing lung capacity were measured in 16 health-service professionals (8 medical doctors and 8
laboratory technicians) working at the pathoanatomic laboratory for at least 4 years with daily exposure 8+1 hours. Con-
trol group employed 16 males, which were matched by age and stature to members of the exposed group. Only non-smok-
ers were included in the study. Spirometric parameters in study participants exposed to formaldehyde fumes compared to
control group were not significantly different indicating absence of restrictive and/or obstructive deterioration of lung
function in exposed group. The only parameter differing in two groups was blood volume of pulmonary capillaries (Vc’)
which was significantly larger in a group exposed to formaldehyde fumes. The possibility that the hyperemic lung reac-
tion is the consequence of the exposure to formaldehyde fumes should be further explored.
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Introduction
Formaldehyde is widely used as a preserving, disin-
fecting and embalming agent. In addition to its technical
benefits, formaldehyde has eliminated many health haz-
ards during histological procedures in anatomy and pa-
thology laboratories. Paradoxically, formaldehyde itself is
a noxious chemical, highly unpleasant to the user, and a
well-recognized occupational health hazard1–4. Formalde-
hyde has been reported to produce allergic contact der-
matitis5, neurobehavioral changes6 and carcinogenesis7.
Symptoms of respiratory irritancy and effects on pul-
monary function have been examined in studies of both
indoor and ambient air exposure to formaldehyde8–12. Ex-
posure to formaldehyde fumes is almost exclusively occu-
pational, and has been investigated in workers in the
production of resinembedded fibreglass13–14, chemicals,
furniture, and wood products15–18 or through employ-
ment in the funeral services industry19. Short-term ef-
fects of formaldehyde exposure included symptoms of ir-
ritation of the eye and respiratory tract. Workers in these
studies were exposed to mean formaldehyde concentra-
tions of 0.16 ppm (0.10–0.12 mg/m3) and greater. In a
survey in which the dosage of exposure was consider-
ed10,20 formaldehyde was a statistically significant predic-
tor of symptoms of eye, nose and throat irritation, phlegm,
cough and chest complaints. Short-term effects of occu-
pational exposure to formaldehyde fumes on lung func-
tion were also investigated but with controversial conclu-
sions. Some studies reported decreased lung function in
workers exposed to formaldehyde9–11 others concluded
that the formaldehyde was not associated with decre-
ments in lung function8,12. Asthmatic symptoms and low-
ered FEV1, MEFs in studies by Fransman et al.
9 and by
Bender11 showed dose-response effects but in both stud-
ies authors concluded that lung function changes are re-
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versible. Since the long-term effects of professional expo-
sure to formaldehyde fumes on lung function are not well
established, the aim of the present study is to examine
lung function parameters in persons working 4–20 yrs. in
pathoanatomic laboratory.
Materials and Methods
The present study was designed to examine long-term
effects of professional exposure to formaldehyde fumes
on lung function. Exposed group encompasses 16 male
health-service professionals (8 medical doctors and 8 lab-
oratory technicians) working at the University of Split.
All exposed examinees were working in the pathoana-
tomic laboratory for at least 4 years with daily exposure
8±1 hours. Control group employed 16 males that were
matched by age and stature to exposed group. To avoid
possible additive or synergistic effects of smoking on
lung function21–23, only non-smokers were included in
the study. All 32 examinees voluntarily participated in
the present study.
The following pulmonary functionmeasurements were
considered: forced vital capacity (FVC), forced expiratory
volume in 1st second (FEV1), forced midexpiratory flow
rates (PEF, MEF25, MEF50), diffusing lung capacity for
carbon monoxide (DLCO), Kroch constant (DLCO/VA),
blood volume of pulmonary capillaries (Vc’) and mem-
brane diffusion capacity (Dm).
Forced spirometry measurements were recorded by
Masterlab from Jaeger instrument. The testing was per-
formed in a sitting position without a noseclip. Each
examinee was instructed to perform acceptable maneu-
vers. The FVC maneuver was repeated three times and
the best values were taken from any of the acceptable
tracings.
For a single breath (10 s breathhold) DLCO measure-
ments an inspired concentration of 0.3% CO, 0% He, 21%
O2, and balance N2 was used. Before the DLCO test was
performed each subject was instructed in all required
maneuvers, emphasizing the importance of giving a sign
when at the level or residual volume (maximal expira-
tion) inhaling the test gas mixture rapidly to vital capac-
ity, continuing to hold the breath (assisted by the valve
system) for 10 s, and exhaling volume of at least 2.0 L
rapidly. The effective breathhold time included two-
-thirds of the inspiratory time and the portion of the ex-
piratory time until one half of the alveolar sample was
obtained. This procedure is automatically built into the
instrument. Two satisfactory tests were carried out with
an interval of at least 4 minutes between the two tests
and their average was taken. The subjects rested for at
least 30 minutes before the start of each test. One train-
ed technician did 94% of the tests. All tests were per-
formed between 9 a.m. and 1 p.m.
The reference values for DLCO, DLCO/VA where VA
is the alveolar volume, Dm and Vc’ were those of Cotes
and Hall24 and for forced spirometry parameters those of
Cotes25. These reference values agreed well with values
for healthy population tested in our laboratory26.
Dm and Vc’ estimates were done according to the
Roughton and Foster’s formula:
1 / TLCO = 1 / Dm + 1 / Vc’
Where TLCO is carbon monoxide transfer factor,  is the
rate of CO binding to hemoglobin and is generally de-
pendent on the examinee’s mean oxygen tension in the
pulmonary capillaries (Pc’O2), Hb and COHb, as follows:
1 /  (ml blood min mmHg ml–1 CO) =
0.006 (Pc’O2(mmHg) + 0.33) 14.6 / Hb (g/dl
–1)
(1 – % COHb / 100)
Pc’O2 may be assessed as:
Pc’O2 (mmHg) = PAO2 (mmHg) – 10
or more accurately, from oxygen consumption and Dm.
In order to calculate Dm and Vc’ from equations (1) – (3),
measurements were made at two levels of alveolar oxy-
gen tension, room air and after breathing 100% oxygen
for 10 min, providing two equations with two unknowns:
Dm and Vc’. The explicit solutions are:
Vc’ (ml) = (Hb / 14.6)
0.006 PA O2 (oxygen) – PA O2 (air)
1 / DLCO (air) – 1 / DLCO (oxygen)
Dm (ml x CO/mmHg x min)=
1 / .(oxygen) – 1 / .(room air)
1 / .(oxygen) 1 / DLCO (air) –
1 / .(air) 1 / DLCO (oxygen)
The pulmonary function test results were interpreted
using the criteria of Konig et al.27:
(a) normal finding: FVC  80% predicted; FEV1/FVC 
70%; MEF25, MEF50, and MEF75  60% predicted and
DLCO  80% predicted;
(b) restrictive impairment: FVC < 80% predicted and
FEV1/FEC  70%;
(c) obstructive impairment: FEV1/FVC < 70%;
(d) isolated DLCO reduction: DLCO < 80% predicted, as
a sole finding and
(e) DLCO > 120% predicted was described as isolated
DLCO increase.
Comparison between study participants exposed to
formaldehyde fumes and control group in diffusing lung
capacity and in lung function parameters was carried out
by means of Student’s t-test for independent samples.
The difference between groups at p < 0.05 was consid-
ered as statistically significant.
Results
Descriptive statistics of age, height, weight, body
mass index (BMI = weight (kg) / height (m)2), years of
professional exposure to formaldehyde fumes and lung
function parameters (percentage of expected values) in
16 exposed participants is presented in Table 1. Table 2
provides the results of the comparison of spirometric pa-
rameters in study participants exposed to formaldehyde
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fumes compared to control group. Exposed group did not
show any difference in mean values of either examined
forced spirometry parameters – FVC, FEV1, PEF, MEF25,
MEF50 and MEF75. However, 25% of exposed participants
showed incipient changes in small respiratory airways.
The comparison of diffusing lung capacity for carbon
monoxide (DLCO), Krogh constant (DLCO/VA), blood
volume of pulmonary capillaries (Vc’) and membrane dif-
fusion capacity (Dm) in participants exposed to formalde-
hyde fumes compared to control group is shown in Table
3. The measured values of diffusing lung capacity for car-
bon monoxide (DLCO) and membrane diffusion capacity
(Dm) in exposed group fell within expected referent val-
ues. While, blood volume of pulmonary capillaries (Vc’)
showed to be significantly higher in a group exposed to
formaldehyde fumes in comparison with control group.
Discussion
Occupational hazards of formaldehyde were thor-
oughly investigated but the studies were primarily deal-
ing with its possible carcinogenic effects28–32. Only small
proportion of studies were oriented towards inflamma-
tory reactions of respiratory system relating exposure to
formaldehyde fumes inhalation to dynamic changes (short-
-term and long-term) in bronchial and pulmonary symp-
toms and function.
Various studies provided the evidences that formalde-
hyde is an irritant of the respiratory tract13,17,19,33 that
causes nonproductive cough, breathing problems, eye
tears and nose dripping. There is a correlation between
clinical symptoms and concentration of formaldehyde in
the workplace20. Usual concentration provoking symp-
toms being from 10 to 20 ppm.
The possibility of the occurrence of asthmatic reac-
tions, or even asthma itself was also suggested by some
authors34. The inhalation of formaldehyde fumes causes
bronchial hyperactivity35 and – according to some au-
thors – the reductions of air circulation speed as well15.
However, the increases of respiratory values were re-
ported in some other studies16.
Results of investigations of effects on pulmonary
function in occupationally exposed populations are some-
what conflicting. Pre-shift reductions (considered indica-
tive of chronic occupational exposure) of up to 12% in pa-
rameters of lung function (e.g., forced vital capacity,
forced expiratory volume, forced expiratory flow rate)
were reported in a number of smaller studies of chemical,
furniture and plywood workers15–18,36. In general, these
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TABLE 1
AGE, HEIGHT, WEIGHT, BMI, YEARS OF EXPOSURE AND
LUNG FUNCTION PARAMETERS (% EXPECTED) IN STUDY
PARTICIPANTS EXPOSED TO FORMALDEHYDE FUMES (N=16)
X SD Min Max
Age (yrs) 38.06 8.16 25 52
Height (cm) 166.5 7.4 156 182
Weight (kg) 68.88 12.04 55 104
BMI (kg/m2) 24.78 3.44 19.71 33.28
Exposure (yrs) 12.38 5.21 4 20
FVC (%) 111.43 14.35 90.1 139
FEV1 (%) 111.95 13.09 91.7 137
FEV1/VC (%) 107.81 5.69 93.9 117
PEF (%) 99.03 19.02 62.1 124
MEF50 (%) 104.27 22.95 71.9 139
MEF25 (%) 102.18 22.32 69.2 143
DLCO (%) 101.13 27.44 63 141
DLCO/VA (%) 95.94 11.13 70 112
Vc’ (%) 103.38 18.18 76 132
Dm (%) 88.38 11.12 72 111
BMI – weight (kg) / height (m)2, FVC – forced vital capacity,
FEV1 – forced expiratory volume in 1st second, PEF, MEF25,
MEF50 – forced midexpiratory flow rates, DLCO – diffusing lung
capacity for carbon monoxide, DLCO/VA – Kroch constant, Vc’ –
blood volume of pulmonary capillaries, Dm – membrane diffu-
sion capacity
TABLE 2
LUNG FUNCTION PARAMETERS IN STUDY PARTICIPANTS







X SD X SD
FVC (%) 111 14 106 11 ns
FEV1 (%) 112 13 102 9 ns
FEV1/VC (%) 108 6 96 6 ns
PEF (%) 99 19 92 13 ns
MEF50 (%) 104 22 110 20 ns
MEF25 (%) 102 22 105 25 ns
FVC – forced vital capacity, FEV1 – forced expiratory volume in
1st second, PEF, MEF25, MEF50 – forced midexpiratory flow rat-
es, ns – nonsignificant
TABLE 3
DIFFUSING LUNG CAPACITY PARAMETERS IN STUDY PARTICI-







X SD X SD p
DLCO (%) 101 27 105 6 ns
DLCO/VA
(%)
95 11 90 5 ns
Vc’ (%) 103 18 81 9 <0.001
Dm (%) 88 11 89 11 ns
DLCO – diffusing lung capacity for carbon monoxide, DLCO/VA
– Krogh constant, Vc’ – blood volume of pulmonary capillaries,
Dm – membrane diffusion capacity, ns – nonsignificant
effects of lung function were small and transient over a
work shift, with a cumulative effect over several years
that was reversible after relatively short periods without
exposure (e.g. 4 weeks); effects were more obvious in
non-smokers than in smokers37,38. In the subset of these
investigations in which exposure was monitored for indi-
viduals (i.e., excluding only that of Malaka and Kodama
199018), workers were exposed to mean concentrations.
The present study examines lung function parame-
ters in laboratory technicians and medical doctors pro-
fessionally exposed to formaldehyde. The long-term ef-
fects of exposure were examined by comparing their
spirometric indicators and diffusing capacity parameters
with non-exposed subjects. The study showed that flow/
volume curves were within reference values in all 16 ex-
amined subjects (Table 1).
The clinical symptoms of nonproductive cough and
eye tears were present in 80% of exposed subjects, whe-
reas 20% of the examinees have subjectively present
breathing complaints.
When compared to unexposed controls the only lung
function parameter significantly differing in exposed
group was the blood volume of pulmonary capillaries,
which was significantly higher in exposed group. The in-
crease of the blood volume of pulmonary capillaries in
persons exposed to formaldehyde is also radiologically
confirmed39,40. One of the explanatory hypotheses in-
cludes the hyperemic lung reaction as the consequence of
the exposure to environmental irritants including form-
aldehyde.
Although mean values of all other parameters were
within normal ranges it should be mentioned that the
lungs’ diffusion capacities in 16 examinees professionally
exposed to formaldehyde showed to be rather divergent.
Increased diffusion capacity has been recorded in eight
examinees (50%), a decrease of diffusion capacity has
been recorded in three examinees, whereas only in five
examinees the recorded values fall within normal range.
The diffusion capacity of the lungs showed a tendency to
be related with the years of exposure: exposure to form-
aldehyde fumes inhalation up to ten years causes an in-
crease of the diffusion capacity of the lungs; exposure to
formaldehyde fumes inhalation more than ten years
causes a decrease of the diffusion capacity of the lungs. A
larger sample is needed to provide sufficient evidences to
confirm above findings.
Conclusions
The present study of lung function in 16 persons
working in pathoanatomic laboratory being daily profes-
sionally exposed to formaldehyde fumes showed that:
¿ No respiratory function impairments, either of the
obstructive or restrictive type, were detected;
¿ No relation between clinical symptoms and pulmo-
nary function tests has been found;
¿ When compared to unexposed controls the only
lung function parameter significantly differing in
exposed group was the blood volume of pulmonary
capillaries, which was considerably higher in ex-
posed group. The possibility that the hyperemic
lung reaction is the consequence of the exposure to
formaldehyde fumes should be further explored.
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PLU]NA FUNKCIJA U OSOBA PROFESIONALNO IZLO@ENIH PARAMA FORMALDEHIDA
S A @ E T A K
Dinami~ka spirometrija i difuzijski kapacitet plu}a odre|en je u 16 ispitanika koji rade u patoanatomskom labo-
ratoriju. U istra`ivanje su uklju~eni samo nepu{a~i. Minimalna dnevna izlo`enost formaldehidu je bila osam sati, a svi
ispitanici rade najmanje ~etiri godine u laboratoriju. Kontrolnu skupinu sa~injavalo je 16 ispitanika sli~ne dobi koji nisu
bili izlo`eni udisanju formaldehida. Nisu prona|ene zna~ajne smetnje u ventilacijskim vrijednostima kao ni restrik-
cijski, a ni opstrukcijski poreme}aji ventilacije. Pove}an difuzijski kapacitet zabilje`en je u 50%, a smanjen u 18,8%
ispitanika skupine izlo`ene formaldehidu. Ova studija je pokazala da je me|u provedenim testovima plu}ne funkcije
samo razina volumena krvi plu}nih kapilara statisti~ki zna~ajno razli~ita izme|u dviju skupina. Ispitanici profesio-
nalno izlo`eni parama formaldehida pokazali su pove}anje u odnosu na kontrolnu skupinu u razini volumena krvi
plu}nih kapilara. To je po mi{ljenju autora posljedica hiperemijske reakcije u plu}ima, {to je radiolo{ki i potvr|eno.
